Noviro grants rights to Sumitomo

Novirio Pharmaceuticals (Montpellier, France) granted commercialization rights for its LdT nucleoside for the treatment of hepatitis B infection to Sumitomo Pharmaceuticals (Osaka, Japan). Sumitomo wi...